Curcumin Solid Formulation for Local Head and Neck Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current chemopreventive agents for head and neck squamous cell cancers (HNSCC) face challenges due to poor bioavailability and toxicity issues, particularly with curcumin, which requires high doses and has difficulty being absorbed systemically, making it hard for patients to swallow large pills post-treatment when dysphagia occurs.
Innovation Solution
The development of solid formulations such as chewing gum and lozenges for local and sustained delivery of curcumin and other therapeutic agents through the oral mucosa, bypassing systemic bioavailability issues and using buffers and carriers to enhance absorption and reduce pill burden.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If high doses of curcumin are administered orally to overcome poor bioavailability, then therapeutically relevant concentrations can be achieved, but patients experience difficulty swallowing large pills due to dysphagia
Solution Approach 1:
The patent divides the large pill into multiple smaller dosage units or uses a formulation that can be broken down into smaller pieces, making it easier for dysphagic patients to consume the required high dose of curcumin without swallowing a single large pill
Solution Approach 2:
The patent employs a sustained-release formulation that maintains curcumin at therapeutically relevant concentrations locally in the gastrointestinal tract over an extended period, allowing for lower total dosages that are easier to administer while still achieving the desired therapeutic effect
2Reliability
If curcumin is administered systemically, then it can reach target tissues, but poor gastrointestinal absorption limits bioavailability
Solution Approach 1:
The patent uses absorption enhancers or permeation promoters as intermediary substances that facilitate curcumin's passage through the gastrointestinal barrier, significantly improving its bioavailability without requiring increased dosages
Solution Approach 2:
The patent formulates curcumin with carriers, cyclodextrins, or lipid-based systems that improve its solubility and absorption characteristics, transforming the poor-absorbing curcumin into a composite formulation with enhanced gastrointestinal uptake
3Reliability
If conventional chemopreventive agents are used, then tumor progression may be prevented, but toxicity issues limit long-term use
Solution Approach 1:
The patent modifies the dosing parameters of curcumin through sustained-release formulation, maintaining lower but continuous concentrations that prevent tumor progression while avoiding the peak concentrations that cause toxicity, enabling safe long-term chemoprevention
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for effective, localized delivery of curcumin and other agents to achieve therapeutically relevant concentrations in the mucosa, reducing toxicity and improving compliance by providing a convenient, non-invasive method for patients to administer chemopreventive agents, even when swallowing is impaired.
Implementation Method 1
solid formulations and methods for the local and sustained slow-release delivery of therapies in the oral cavity
Data Source
AI summary
The invention features formulations for the local delivery of therapeutically effective doses of curcumin to treat head and neck disorders and upper aerodigestive disorders. Also disclosed are use of the formulations for delivery of other phytochemicals, or the combination of phytochemicals for the treatment of said disorders. Furthermore, these formulations can be used to deliver the recommended daily allowance of vitamins and/or minerals to children or adults.